{
}
J.P. Morgan Asset Management has added its JPMorgan Private Markets Fund to the Schwab Alternative Investment OneSource platform, enhancing access to private market investments for individual investors. This fund offers a diversified portfolio of small and mid-market companies, employing innovative strategies to deliver long-term value. With a management team boasting over 40 years of experience, the fund aims to capitalize on diverse opportunities across various sectors and geographies.
J.P. Morgan Asset Management has announced the addition of its JPMorgan Private Markets Fund to the Schwab Alternative Investment OneSource platform, enhancing access to private market investments for individual investors. The fund offers a diversified portfolio of small and mid-market companies, employing innovative strategies to deliver long-term value. This follows the previous inclusion of the JPMorgan Real Estate Income Trust in 2024, further expanding investment options available through Schwab.
J.P. Morgan Asset Management has launched its JPMorgan Private Markets Fund on the Schwab Alternative Investment OneSource platform, providing investors access to a diversified portfolio of small and mid-market companies. This fund employs innovative strategies aimed at resilience and long-term growth, managed by a team with over 40 years of experience in private markets. This addition follows the inclusion of the JPMorgan Real Estate Income Trust in 2024, enhancing Schwab's offerings in alternative investments.
UBS has reiterated its Buy rating on Chart Industries, maintaining a price target of $225, significantly above its current trading price of $142.54. Despite a projected EBITDA decline for Q1 2025 and a free cash flow deficit, the company is expected to resume deleveraging in Q2 2025, with revenue growth anticipated at 9% for the year. Moody’s has upgraded its corporate family rating, reflecting strong order growth, while Stifel also maintains a Buy rating with a target of $231.
UBS has lowered its price target for Atlassian Corporation from $330 to $230 while maintaining a Neutral rating, citing budget scrutiny and modest seat expansion rates despite strong gross profit margins and expected net income growth. The stock has dropped over 10% recently but remains up 31% over the past six months. Analysts from KeyBanc and Stephens have differing views, with price targets of $365 and $255, respectively, reflecting confidence in Atlassian's growth potential ahead of its upcoming earnings report and Investor Day.
UBS analyst Batya Levi has reaffirmed a Buy rating on Warner Music Group (NASDAQ: WMG) with a price target of $41, despite adjusting revenue forecasts due to softer advertising revenue. The company anticipates total revenues of $1.52 billion for the fiscal second quarter, reflecting a 2% year-over-year increase, while OIBDA is projected to reach $333 million, indicating a margin improvement. Recent earnings showed a decline in Recorded Music revenue but growth in Music Publishing, with analysts from Citi and FBN Securities also expressing optimism about the company's future prospects.
President Trump is set to unveil his tariff plan at a press conference in the White House Rose Garden, dubbing the day "Liberation Day." The plan aims to reduce U.S. dependence on foreign products and may include reciprocal tariffs, though details remain unclear.Market reactions could be significant, with potential for increased selling if the plan lacks clarity or if tariffs exceed expectations. Attention is particularly focused on the responses from the European Union and China, as uncertainty has already impacted consumer sentiment and raised recession fears.
JPMorgan Chase & Co. is highlighted as a top choice for dividend capture in April, reflecting the resilience of dividend growth stocks during economic downturns. Analysts suggest that these stocks, particularly dividend aristocrats, can provide stability amid market volatility, with many currently trading at attractive valuations. The trend of increasing dividend payouts, especially in the tech sector, signals a promising outlook for income-focused investors.
UBS has raised CryoPort's stock price target to $11 from $10, maintaining a Buy rating, as the company focuses on expanding its cell and gene therapy services. Following the divestiture of its CryoPDP subsidiary for $195 million, CryoPort is expected to enhance its financial position and growth potential, with improved earnings estimates for 2025 and 2026. The strategic move aligns with a strong liquidity position and aims to bolster CryoPort's market presence in the life sciences sector.
Barclays has reduced its Q1 2025 estimates for Novo Nordisk, citing lower-than-expected prescription volumes for Wegovy and Ozempic in the U.S. The bank anticipates sales and operating profit to fall 2% and 3% below Bloomberg consensus, projecting 19% constant-currency sales growth for the full year, below Novo's guidance range.Despite recent positive developments, including Wegovy's removal from the FDA's drug shortage list, prescription trends have remained flat. Analysts are cautious about potential guidance cuts depending on volume recovery in the latter part of the year, while Barclays maintains an Overweight rating and a DKK 900 price target, confident in the long-term prospects of the GLP-1 franchise.
United States Dollar
Currency
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
jpmorgan private markets fund joins schwab alternative investment platform
16:34 01.04.2025
jpmorgan private markets fund joins schwab alternative investment platform
United States Dollar
JPMorgan Chase & Co.
The Charles Schwab Corporation
USA
Shawn Khazzam
Show more
16:34 01.04.2025
jpmorgan private markets fund launched on schwab alternative investment platform
United States Dollar
JPMorgan Chase & Co.
The Charles Schwab Corporation
USA
Shawn Khazzam
Show more
16:34 01.04.2025
ubs maintains buy rating for chart industries with target of 225 dollars
16:28 01.04.2025
ubs lowers atlassian price target to 230 maintains neutral rating
16:22 01.04.2025
ubs maintains buy rating on warner music with 41 dollar target
16:22 01.04.2025
Trump to unveil tariff plan on Liberation Day amid market uncertainty
Euro
United States Dollar
Apple Inc.
Microsoft Corp
MEX
CAN
CHN
USA
Donald Trump
Karoline Leavitt
Show more
16:18 01.04.2025
dividend stocks poised for growth amid economic uncertainty in 2024
16:17 01.04.2025
ubs raises cryoport price target to eleven maintains buy rating
16:12 01.04.2025
barclays lowers novo nordisk estimates on weak us drug volumes
16:12 01.04.2025
Trending
Subcategory
Corporate News
Industry Trends
Stock Market Updates
Industry Mergers & Acquisitions
Workplace Trends
Global Financial Events
Banking Regulations
Finance Mergers & Acquisitions
Retail and Consumer Goods
CEO Changes
Market Analysis and Predictions
Startups & Entrepreneurship
Government Policies
Central Bank Actions
Domestic Politics
Global Trade Developments
Private Equity Deals
Financial Scams and Security
Government Economic Policies
Supply Chain Management
Countries:
Companies:
JPMorgan Chase & Co.
Tesla, Inc.
Barclays PLC
Credit Suisse Lux Digital Healt
Bank of America Corporation
UBS Group AG
Deutsche Bank Money Market PP
Apple Inc.
BNP Paribas SA
The Goldman Sachs Group, Inc.
Wells Fargo & Company
Commerzbank AG
UniCredit S.p.A.
Banco Santander, S.A.
SpaceXCoin USD
Amazon.com, Inc.
Morgan Stanley
Danske Bank A/S
NVIDIA Corporation
Google Inc.
Currencies:
United States Dollar
Euro
British Pound Sterling
Chinese Yuan
Swiss Franc
Indian Rupee
Japanese Yen
Danish Krone
Hong Kong Dollar
Australian Dollar
South Korean Won
Singapore Dollar
Russian Ruble
Offshore Chinese Yuan
Canadian Dollar
Mexican Peso
Indonesian Rupiah
Turkish Lira
Chilean Peso
United Arab Emirates Dirham
People: